Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 1/2013

01-02-2013 | Case Report

Community-acquired left-sided Pseudomonas aeruginosa endocarditis in a patient without intravenous drug use

Authors: M. Yilmaz, H. Sunar, A. Mert

Published in: Infection | Issue 1/2013

Login to get access

Abstract

We present a case of community-acquired left-sided Pseudomonas aeruginosa endocarditis in a person without intravenous drug use. The patient presented with facial numbness and did not have any predisposing condition for endocarditis. He was treated successfully with valvular surgery, along with combination antibiotics.
Literature
1.
Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;. doi:10.​1007/​s15010-012-0285-y.PubMed
2.
Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276–86.PubMedCrossRef
3.
Komshian SV, Tablan OC, Palutke W, Reyes MP. Characteristics of left-sided endocarditis due to Pseudomonas aeruginosa in the Detroit Medical Center. Rev Infect Dis. 1990;12:693–702.PubMedCrossRef
4.
Reyes MP, Lerner AM. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev Infect Dis. 1983;5:314–21.PubMedCrossRef
5.
Gavin PJ, Suseno MT, Cook FV, Peterson LR, Thomson RB Jr. Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin. Diagn Microbiol Infect Dis. 2003;47:427–430. doi:S073288930300135​4.PubMedCrossRef
6.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8. doi:10.​1086/​313753.PubMedCrossRef
7.
8.
9.
Marcus N, Ashkenazi S, Samra Z, Cohen A, Livni G. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Infection. 2008;36:421–6. doi:10.​1007/​s15010-008-7328-4.PubMedCrossRef
10.
Weissler A, Perl L, Neuman Y, Mekori YA, Mor A. Neurologic manifestations as presenting symptoms of endocarditis. Isr Med Assoc J. 2010;12:472–6.PubMed
11.
Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, et al. Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008;47:23–30. doi:10.​1086/​588663.PubMedCrossRef
12.
13.
Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43:1379–82.PubMed
Metadata
Title
Community-acquired left-sided Pseudomonas aeruginosa endocarditis in a patient without intravenous drug use
Authors
M. Yilmaz
H. Sunar
A. Mert
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 1/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0306-x

Other articles of this Issue 1/2013

Infection 1/2013 Go to the issue

Brief Report

National MRSA rates run along with fair play of national football teams: a cross-national data analysis of the European Football Championship, 2008

Clinical and Epidemiological Study

Variation in antibiotic prescriptions: is area deprivation an explanation? Analysis of 1.2 million children in Germany

Images in Infection

Spinal cord toxoplasmosis

Brief Report

Why is antimicrobial de-escalation under-prescribed for urinary tract infections?

Case Report

Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma

Images in Infection

Severe MRSA necrotizing pneumonia

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits